Acute Porphyria Drug Database

Monograph

B02BD08 - Coagulation Factor VIIa
Not porphyrinogenic
NP

Rationale
Enzyme. No CYP-interactions.
Chemical description
Recombinat factor VII administered as infusion in bleeding or surgery in patients with hemophilia and antibodies agains factor VIII or IX.

Similar drugs
Explore alternative drugs in similar therapeutic classes B02B / B02BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
CEVENFACTA · CEVENFACTA, 1mg, poeder en oplosmiddel voor oplossing voor injectie · CEVENFACTA, 2mg, poeder en oplosmiddel voor oplossing voor injectie · CEVENFACTA, 5mg, poeder en oplosmiddel voor oplossing voor injectie · NovoSeven · NovoSeven 1 mg (50 KIE) poeder en oplosmiddel voor oplossing voor injectie · NovoSeven 2 mg (100 KIE) poeder en oplosmiddel voor oplossing voor injectie · NovoSeven 5 mg (250 KIE) poeder en oplosmiddel voor oplossing voor injectie · NovoSeven 8 mg (400 KIE) poeder en oplosmiddel voor oplossing voor injectie
Belgium
Cevenfacta · Cevenfacta 1 mg sol. inj. (pdr. + solv.) i.v. ser. préremplie flac. · Cevenfacta 2 mg sol. inj. (pdr. + solv.) i.v. ser. préremplie flac. · Cevenfacta 5 mg sol. inj. (pdr. + solv.) i.v. ser. préremplie flac. · NovoSeven · NovoSeven 1 mg sol. inj. (pdr. + solv.) i.v. flac. · NovoSeven 2 mg sol. inj. (pdr. + solv.) i.v. flac. · NovoSeven 5 mg sol. inj. (pdr. + solv.) i.v. flac. · NovoSeven 8 mg sol. inj. (pdr. + solv.) i.v. flac.
United Kingdom
Cevenfacta · Cevenfacta 1mg (45,000units) powder and solvent for solution for injection vials · Cevenfacta 2mg (90,000units) powder and solvent for solution for injection vials · Cevenfacta 5mg (225,000units) powder and solvent for solution for injection vials · NovoSeven · NovoSeven 120,000unit powder and solvent for solution for injection vials · NovoSeven 1mg (50,000units) powder and solvent for solution for injection pre-filled syringes · NovoSeven 1mg (50,000units) powder and solvent for solution for injection vials · NovoSeven 240,000unit powder and solvent for solution for injection vials · NovoSeven 2mg (100,000units) powder and solvent for solution for injection pre-filled syringes · NovoSeven 2mg (100,000units) powder and solvent for solution for injection vials · NovoSeven 5mg (250,000units) powder and solvent for solution for injection pre-filled syringes · NovoSeven 5mg (250,000units) powder and solvent for solution for injection vials · NovoSeven 60,000unit powder and solvent for solution for injection vials · NovoSeven 8mg (400,000units) powder and solvent for solution for injection pre-filled syringes · NovoSeven 8mg (400,000units) powder and solvent for solution for injection vials
Denmark
CEVENFACTA · Novoseven
Norway
NovoSeven
Poland
Cevenfacta · NovoSeven
Luxembourg
CEVENFACTA · CEVENFACTA (225 KUI) · CEVENFACTA (45 KUI) · CEVENFACTA (90 KUI) · NovoSeven
Iceland
Cevenfacta · NovoSeven
Finland
CEVENFACTA · Novoseven
Latvia
Cevenfacta · NovoSeven
Serbia
NovoSeven · NovoSeven®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙